File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1186/1748-717X-6-53
- Scopus: eid_2-s2.0-79956226155
- PMID: 21600025
- WOS: WOS:000292207800001
Supplementary
- Citations:
- Appears in Collections:
Article: Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons
Title | Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons |
---|---|
Authors | |
Keywords | T1N0 glottic cancer Biologically effective dose Anterior commissure 6 MV Radiotherapy |
Issue Date | 2011 |
Citation | Radiation Oncology, 2011, v. 6, n. 1 How to Cite? |
Abstract | Background: To evaluate prognostic factors that may influence local control (LC) of T1N0 glottic cancer treated by primary radiotherapy (RT) with 6 MV photons.Methods: We retrospectively reviewed the medical records of 433 consecutive patients with T1N0 glottic cancer treated between 1983 and 2005 by RT in our institution. All patients were treated with 6 MV photons. One hundred and seventy seven (41%) patients received 52.5 Gy in 23 fractions with 2.5 Gy/fraction, and 256 (59%) patients received 66 Gy in 33 fractions with 2 Gy/fraction.Results: The median follow-up time was 10.5 years. The 10-year LC rates were 91% and 87% for T1a and T1b respectively. Multivariate analysis showed LC rate was adversely affected by poorly differentiated histology (Hazard Ratio [HR]: 7.5, p = 0.035); involvement of anterior commissure (HR: 2.34, p = 0.011); fraction size of 2.0 Gy (HR: 2.17, p = 0.035) and tumor biologically effective dose (BED) < 65 Gy 15 (HR: 3.38, p = 0.017).Conclusions: The negative impact of anterior commissure involvement could be overcome by delivering a higher tumor BED through using fraction size of > 2.0 Gy. We recommend that fraction size > 2.0 Gy should be utilized, for radiation schedules with five daily fractions each week. © 2011 Tong et al; licensee BioMed Central Ltd. |
Persistent Identifier | http://hdl.handle.net/10722/251611 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tong, Chi Chung | - |
dc.contributor.author | Au, Kwok Hung | - |
dc.contributor.author | Ngan, Roger K.C. | - |
dc.contributor.author | Chow, Sin Ming | - |
dc.contributor.author | Cheung, Foon Yiu | - |
dc.contributor.author | Fu, Yiu Tung | - |
dc.contributor.author | Au, Joseph S.K. | - |
dc.contributor.author | Law, Stephen C.K. | - |
dc.date.accessioned | 2018-03-08T05:00:28Z | - |
dc.date.available | 2018-03-08T05:00:28Z | - |
dc.date.issued | 2011 | - |
dc.identifier.citation | Radiation Oncology, 2011, v. 6, n. 1 | - |
dc.identifier.uri | http://hdl.handle.net/10722/251611 | - |
dc.description.abstract | Background: To evaluate prognostic factors that may influence local control (LC) of T1N0 glottic cancer treated by primary radiotherapy (RT) with 6 MV photons.Methods: We retrospectively reviewed the medical records of 433 consecutive patients with T1N0 glottic cancer treated between 1983 and 2005 by RT in our institution. All patients were treated with 6 MV photons. One hundred and seventy seven (41%) patients received 52.5 Gy in 23 fractions with 2.5 Gy/fraction, and 256 (59%) patients received 66 Gy in 33 fractions with 2 Gy/fraction.Results: The median follow-up time was 10.5 years. The 10-year LC rates were 91% and 87% for T1a and T1b respectively. Multivariate analysis showed LC rate was adversely affected by poorly differentiated histology (Hazard Ratio [HR]: 7.5, p = 0.035); involvement of anterior commissure (HR: 2.34, p = 0.011); fraction size of 2.0 Gy (HR: 2.17, p = 0.035) and tumor biologically effective dose (BED) < 65 Gy 15 (HR: 3.38, p = 0.017).Conclusions: The negative impact of anterior commissure involvement could be overcome by delivering a higher tumor BED through using fraction size of > 2.0 Gy. We recommend that fraction size > 2.0 Gy should be utilized, for radiation schedules with five daily fractions each week. © 2011 Tong et al; licensee BioMed Central Ltd. | - |
dc.language | eng | - |
dc.relation.ispartof | Radiation Oncology | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | T1N0 glottic cancer | - |
dc.subject | Biologically effective dose | - |
dc.subject | Anterior commissure | - |
dc.subject | 6 MV | - |
dc.subject | Radiotherapy | - |
dc.title | Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons | - |
dc.type | Article | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1186/1748-717X-6-53 | - |
dc.identifier.pmid | 21600025 | - |
dc.identifier.scopus | eid_2-s2.0-79956226155 | - |
dc.identifier.volume | 6 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | null | - |
dc.identifier.epage | null | - |
dc.identifier.eissn | 1748-717X | - |
dc.identifier.isi | WOS:000292207800001 | - |
dc.identifier.issnl | 1748-717X | - |